18 June 2002
Case presentation of gastrinoma combined with gastric carcinoid with the longest survival record - Zollinger-Ellison syndrome: pathophysiology, diagnosis and therapy
Edward Sito, Jan W Konturek, Sławomir Kwiecień, Krzysztof Lorens, Władysław Bielański, Piotr C Konturek, Stanisław J Konturek, Andrzej Bobrzyński, Teresa Pawlik, Danuta Karcz, Hany Areny, Tomasz StachuraMed Sci Monit 2002; 8(6): CS43-59 :: ID: 420805
Abstract
BACKGROUND: Zollinger-Ellison syndrome is a very rare disease caused bytumor with gastrin producing cells accompanied by hypergastrinemia leading to gastric hypersecretionand peptic ulcers and their complications.CASE STUDY: Female case of gastrinoma (Zollinger-Ellison syndrome;Z-E) with a record of 38 yrs of survival. Acute gastro-duodenal ulcers started at 28 yr of age and Z-Ewas diagnosed by using gastrin assays. Basal and maximal acid outputs and ratio of basal/maximal outputswere away over normal limits. Because of ulcer recurrence and complications, patient was subjected toseveral gastric surgeries but refused total gastrectomy. She was also treated with many H2-receptor (R)antagonists and proton-pump inhibitors (PPI), each new drug being initially highly effective but thenshowing declining efficacy except when PPI, lansoprazole was used. The gastrin level rose in the courseof disease from initial high value of 2000 pg/mL to the extreme 4500 ng/mL at present. During the last2 yrs, metastasis mainly to liver developed and they were successfully treated by synthetic octapeptidederivative of somatostatin and, as a result, metastatis partly reduced and plasma gastrin drasticly decreased.Biopsy taken from liver metastasis showed the presence of typical gastrinoma cells with gastrin and chromogranin,while that from oxyntic mucosa revealed the ECL-cell hyperplasia with carcinoid tumors and unexpectedgastric atrophy.CONCLUSIONS: This phenomenal case described in this article might be the new proven evidenceneeded by gastroenterologists to overturn the traditional treatment using total gastrectomy as a treatmentof choice to the partial gastrectomy combined with proton pump inhibitors.
Keywords: Anti-Ulcer Agents, Carcinoid Tumor, Gastrinoma, Histamine H2 Antagonists, Survivors, Zollinger-Ellison Syndrome
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952